Stage 2 Sacral Pressure Ulcer Treatment
Apply hydrocolloid or foam dressings to the wound, provide protein supplementation, and ensure pressure redistribution with an alternative foam mattress. 1, 2
Wound Dressing Management
- Use hydrocolloid dressings as first-line therapy, as they are superior to gauze dressings for reducing wound size (weak recommendation, low-quality evidence). 1, 2
- Foam dressings are an equivalent alternative to hydrocolloid dressings for complete wound healing (moderate-quality evidence). 3, 2
- Select dressings based on exudate control, patient comfort, and cost-effectiveness rather than antimicrobial properties. 2
- Avoid dextranomer paste, as it is inferior to other wound dressings for reducing ulcer area. 1, 3
Common Pitfall
- Do not use standard gauze dressings, as they are less effective than hydrocolloid or foam options for Stage 2 ulcers. 1, 2
Pressure Redistribution
- Use alternative foam mattresses rather than standard hospital mattresses, which provides a 69% relative risk reduction in pressure ulcer incidence. 2
- Reposition the patient regularly to prevent sustained localized pressure that causes microthrombi and tissue ischemia. 4
- Avoid expensive advanced support surfaces (alternating-air, low-air-loss beds) for Stage 2 ulcers, as evidence of superiority is limited and costs are unjustified at this stage. 2
Nutritional Support
- Provide protein or amino acid supplementation to reduce wound size and improve healing rate (weak recommendation, low-quality evidence). 1, 3, 2
- Ensure adequate caloric intake and correct nitrogen balance. 2
- Do not rely on vitamin C supplementation alone, as it has not shown benefit compared to placebo. 1, 3, 2
Debridement Considerations
- For Stage 2 ulcers, gentle removal of any superficial necrotic tissue or callus from wound edges may be needed, but aggressive sharp debridement is typically reserved for deeper ulcers (Stage 3-4). 2
- If any necrotic tissue is present, remove it to allow accurate assessment and eliminate impediments to healing. 2
Adjunctive Therapies
- Consider electrical stimulation as adjunctive therapy if the ulcer fails to show adequate improvement after 4 weeks of standard care (moderate-quality evidence). 1, 3, 2
- Be aware that frail elderly patients are more susceptible to adverse events (primarily skin irritation) with electrical stimulation. 3, 2
- Light therapy may reduce ulcer size without substantial adverse events, though evidence is limited. 3
Infection Management
- Stage 2 ulcers typically do not require systemic antibiotics unless signs of infection develop (spreading cellulitis, systemic signs). 1
- If infection occurs, it is typically polymicrobial including S. aureus, Enterococcus, Gram-negative organisms, and anaerobes. 1
- Direct antibiotic therapy against both aerobic and anaerobic organisms when infection is present. 1, 2
Special Considerations for Sacral Location
- Sacral ulcers have lower recurrence rates after surgical intervention compared to ischial ulcers, though surgery is not indicated for Stage 2 ulcers. 1, 3
- Maintain meticulous skin integrity management, as sacral location increases risk of contamination with urine and feces, which can lead to moisture lesions and infection. 5
- Use barrier products or containment devices to prevent wound contamination in patients with incontinence. 5
When to Escalate Care
- If the ulcer shows inadequate improvement (less than 50% reduction in size) after 4 weeks of standard therapy, consider advanced wound therapies or specialist consultation. 2
- Monitor for signs of progression to Stage 3 or 4, which would require more aggressive debridement and potentially surgical intervention. 2, 6